Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clarin-3 (CLRN3) is a multi-pass membrane protein encoded by the CLRN3 gene in humans and is also known as Transmembrane protein 12 or Usher syndrome type-3A-like protein 1[7][2]. It is predicted to be involved in sensory perception, particularly the perception of sound[6][2]. Clarin-3 is located in the membrane, with reported cytoplasmic expression in tissues such as the intestinal tract, kidney, liver, and gallbladder, and is also found in extracellular exosomes[4][6]. Mutations in CLRN3 have been associated with neurodegenerative disease, specifically a syndrome similar to Usher syndrome type IIIA, as well as with Powassan encephalitis[2]. At present, there are no established interacting drugs, mechanisms of action, or recognized roles as a biomarker or major safety concerns. The protein remains relatively uncharacterized functionally and structurally beyond its predicted membrane localization and potential sensory biological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clarin-3 (CLRN3).